drugset / Trial / NCT02661958

Efficacy, Safety, and Tolerability of S6G5T-1 and S6G5T-3 for the Treatment of Acne Vulgaris

NCT02661958

Phase 2 Completed 726 enrolled Sol-Gel Technologies, Ltd. Accelovance · collab
RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of this study is to evaluate the superiority in efficacy and assess safety and tolerability of the products S6G5T-3 and S6G5T-1 as compared to their respective active components or the vehicle for the treatment of acne.

Timeline

Start
2016-05
Primary completion
2017-10
Completion
2017-10

Drugs

EvaluationDrugModalityDoseRoute
Subject S6G5T-1 Unknown Topical
Subject S6G5T-3 Unknown Topical
Comparator S6G5T-5 Unknown Topical
Comparator S6G5T-6 Unknown Topical
Comparator S6G5T-7 Unknown Topical

Indications